Figure 4.

Interaction between mean heart rate (HR mean) and heart rate coefficient of variation (HR CV) for the primary endpoint (cardiovascular death or heart failure hospitalization) (A), cardiovascular mortality (B), and heart failure hospitalization (C) in placebo (left) and ivabradine (right) patients.